GlassScriptPhysician profile
Robert J Harden
NPI 1942225289
$354.10
in general payments reported to CMS, 2019-2025
8 companies · $78.87 in 2025
The $78.87 reported for 2025 was less than what a typical Child & Adolescent Psychiatry provider received nationally (typical 2025 total: $132).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $117 · 2023: $32.94 · 2024: $125 · 2025: $78.87.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $237.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $237.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $103.97 | 2019 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $99.66 | 2024-2025 | Caplyta |
| Janssen Scientific Affairs, LLC | $43.26 | 2024 | Invega Sustenna |
| Brainsway USA INC | $32.94 | 2023 | |
| Corium, LLC | $30.11 | 2024 | Azstarys |
| Almatica Pharma LLC | $16.75 | 2024 | Loreev Xr |
| Teva Pharmaceuticals USA, INC. | $14.29 | 2024 | Austedo Xr |
| Novo Nordisk INC | $13.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Harden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.